We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Low-Cost System Provides an Alternative to Mohs Surgery

By HospiMedica International staff writers
Posted on 15 Nov 2017
A novel photoelectric therapy system provides a pain free, non-surgical alternative for the treatment of non-melanoma skin cancer and superficial keloid lesions.

The Xstrahl (Camberley, United Kingdom) Photoelectric Therapy System is a mobile, compact, ergonomic superficial X-ray therapy system--operating in the 10-80kV range--designed for superficial radiotherapy and surface electronic brachytherapy of primary malignant epithelial neoplasms and keloids. More...
Typical indications include basal and squamous cell carcinomas, metatypic carcinoma, cutaneous appendage carcinoma, Karposi's sarcoma, Merkel cell carcinoma, Lentigo maligna, Lentigo maligna melanoma, cutaneous lymphomas (B and T cell), and keloids.

Using a depth dose profile planned for the treatment of superficial skin lesions, the system utilizes low energy photons to deliver a high dose output, which enables treatment times to be kept to a minimum, whilst still treating a wide range of skin conditions. The low half-value layer (HVL) of the system allows for higher doses without compromising on depth of delivery, providing a pain free alternative to invasive procedure such as Mohs surgery, especially in lesions found in sensitive areas of the head and neck.

The freestanding, self-contained, unobtrusive, and lightweight system helps provide a reassuring and stress-free patient experience in any clinical facility. The ergonomically designed controls guarantee smooth adjustment and safe, simple patient set-up, and lockable castors guarantee free movement and operation in any clinical space. An added benefit is that photoelectric devices require minimal shielding and uses a 24 V power supply, in comparison higher energy X-ray therapy systems.

“In an era of personalized medicine, we should expect skin cancer treatment to be minimally invasive on the way we look,” said Amanda Tulk, business development director at Xstrahl. “At Xstrahl we have developed a solution that will enable more patients to gain access to a simple but effective and curative way to treat non-melanoma skin cancer.”

Most non-melanoma skin cancers are basal cell carcinoma, the commonest human cancer in Caucasians, and cutaneous squamous cell carcinoma; over 80% of these tumors occur on the skin of the head and neck, and most are easily curable. Death is rare; when it occurs, it does so from metastases’ or neglect. The major predisposing factor is chronic sunshine exposure, particularly in childhood; other factors include fair skin, ionizing radiation, immunosuppression, previous skin malignancy, and premalignant states, such as multiple actinic keratoses.

Related Links:
Xstrahl


Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Gas Analyzer
GE SAM
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: 123RF

AI Platform Screens for Amyloid Cardiomyopathy Using ECG Images

Amyloid cardiomyopathy is a heart disease caused by deposits of misfolded proteins in the cardiac muscle. It is often missed until patients develop serious complications such as heart failure.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.